Nektar Therapeutics (NKTR)

Today's Latest Price: $16.21 USD

0.30 (1.89%)

Updated Oct 29 6:55pm

Add NKTR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

Nektar Therapeutics (NKTR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NKTR.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
14 $80 $17 $31.36 $15.91 97.11%

NKTR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.41 9 1 6 0 0 16

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Nektar Therapeutics's percent of analysts bearish on the stock is lower than nearly 100% of all US stocks.
  • The variance in analysts' estimates of NKTR is less than 0.450000000000003% of all US stocks.
  • NKTR has a higher upside potential (average analyst target price relative to current price) than 95.27% of stocks in the large market cap category.
  • The number of analysts covering the stock of NKTR is greater than 90.56% of Pharmaceutical Products stocks.
  • Nektar Therapeutics's percentage of analysts bullish on the stock is greater than 25.6% of Pharmaceutical Products stocks.
  • The average analyst price target of NKTR is higher than 27.48% of stocks in the large market cap category.
  • Nektar Therapeutics's change in bullishness amongst analysts is lower than nearly 100% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Nektar Therapeutics are SAGE, ESPR and VYGR.

What is the outlook for NKTR? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5235 seconds.